Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1963 1
1964 2
1968 2
1969 2
1973 1
1978 4
1979 3
1980 11
1981 9
1982 5
1983 4
1984 10
1985 9
1986 11
1987 12
1988 7
1989 11
1990 12
1991 18
1992 28
1993 19
1994 24
1995 25
1996 24
1997 27
1998 24
1999 22
2000 31
2001 30
2002 35
2003 31
2004 38
2005 39
2006 65
2007 64
2008 51
2009 59
2010 76
2011 67
2012 60
2013 60
2014 88
2015 68
2016 69
2017 85
2018 114
2019 111
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

1,436 results
Results by year
Filters applied: . Clear all
Page 1
miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
López P, et al. Front Genet 2018. Among authors: Lopez P. PMID 29896216 Free PMC article.
Also, we observed high levels of serum ferritin (p = 0.03), iron content in seminal plasma (p = 0.04), and spermatozoa (p = 0.002), but lower serum Fe (p = 0.007) in obese subjects. In the Ob group, a high expression of miR-155 (p = 0.02) and miR-21 (p = 0.03) was observed in PBMC and miR-122 (p = 0.03) in plasma. ...
Also, we observed high levels of serum ferritin (p = 0.03), iron content in seminal plasma (p = 0.04), and spermatozoa (p
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
Romero-Laorden N, et al. Br J Cancer 2018 - Clinical Trial. Among authors: Lopez-Campos F, Lopez PP. PMID 30131546 Free PMC article.
The primary objective was to evaluate the antitumour activity of abiraterone acetate plus dexamethasone 0.5 mg daily (AA + D) in mCRPC patients progressing to AA + P. Clinically stable mCRPC patients who had prostate-specific antigen (PSA) and/or limited radiographic progression after at least 12 weeks on AA + P, were eligible. ...
The primary objective was to evaluate the antitumour activity of abiraterone acetate plus dexamethasone 0.5 mg daily (AA + D) in mCRPC patie …
1,436 results
Jump to page
Feedback